Matches in SemOpenAlex for { <https://semopenalex.org/work/W1997409302> ?p ?o ?g. }
- W1997409302 endingPage "333" @default.
- W1997409302 startingPage "324" @default.
- W1997409302 abstract "Poor ocular bioavailability of drugs (<1%) from conventional eye drops (ie, solution, suspension, and ointments) is mainly due to the physiologic barriers of the eye. In general, ocular efficacy is closely related to ocular drug bioavailability, which may be enhanced by increasing corneal drug penetration and prolonging precorneal drug residence time. In our current work, we develop and evaluate a new colloidal system, that is, poly(dl-lactide-co-glycolide) (PLGA) nanoparticles for sparfloxacin ophthalmic delivery, to improve precorneal residence time and ocular penetration. Nanoparticles were prepared by nanoprecipitation technique and characterized for various properties such as particle size, zeta potential, in vitro drug release, statistical model fitting, stability, and so forth. Microbiological assay was carried out against Pseudomonas aeruginosa using the cup-plate method. Precorneal residence time was studied in albino rabbits by gamma scintigraphy after radiolabeling of sparfloxacin by Tc-99m. Ocular tolerance of the developed nanosuspension was also studied by the Hen Egg Test-Chorioallantoic Membrane (HET-CAM) method. The developed nanosuspension showed a mean particle size in the range of 180 to 190 nm, suitable for ophthalmic application with zeta potential of -22 mV. In vitro release from the developed nanosuspension showed an extended release profile of sparfloxacin according to the Peppas model. Acquired gamma camera images showed good retention over the entire precorneal area for the developed nanosuspension compared with that of a marketed formulation. The marketed drug formulation cleared very rapidly from the corneal region and reached the systemic circulation through the nasolacrimal drainage system, as significant radioactivity was recorded in kidney and bladder after 6 hours of ocular administration, whereas the developed nanosuspension cleared at a very slow rate (P < .05) and remained at the corneal surface for longer duration, as no radioactivity was observed in the systemic circulation. HET-CAM assay with 0 score in 8 hours indicates the nonirritant property of the developed nanosuspension. The developed lyophilized nanosuspension was found to be stable for a longer duration of time than the conventional marketed formulation with a good shelf life.Poor ocular bioavailability of drugs (<1%) from conventional eye drops is mainly due to the eye physiological barriers. In this study, a new colloidal system, PLGA nanoparticle for sparfloxacin ophthalmic delivery was demonstrated to improve precorneal residence time and ocular penetration. The developed lyophilized nanosuspension was found to be stable for longer duration of time than conventional marketed formulations." @default.
- W1997409302 created "2016-06-24" @default.
- W1997409302 creator A5036299755 @default.
- W1997409302 creator A5040938396 @default.
- W1997409302 creator A5053831779 @default.
- W1997409302 creator A5069509203 @default.
- W1997409302 creator A5088889865 @default.
- W1997409302 creator A5089261501 @default.
- W1997409302 date "2010-04-01" @default.
- W1997409302 modified "2023-09-30" @default.
- W1997409302 title "Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery" @default.
- W1997409302 cites W1591730307 @default.
- W1997409302 cites W1594437063 @default.
- W1997409302 cites W1967521101 @default.
- W1997409302 cites W1979425595 @default.
- W1997409302 cites W1983843529 @default.
- W1997409302 cites W1992155535 @default.
- W1997409302 cites W1992242429 @default.
- W1997409302 cites W1995718072 @default.
- W1997409302 cites W1998975741 @default.
- W1997409302 cites W2000381333 @default.
- W1997409302 cites W2004759520 @default.
- W1997409302 cites W2006960791 @default.
- W1997409302 cites W2009822272 @default.
- W1997409302 cites W2009974403 @default.
- W1997409302 cites W2014325374 @default.
- W1997409302 cites W2026156584 @default.
- W1997409302 cites W2031964173 @default.
- W1997409302 cites W2033563967 @default.
- W1997409302 cites W2033632772 @default.
- W1997409302 cites W2038270569 @default.
- W1997409302 cites W2046525386 @default.
- W1997409302 cites W2048712874 @default.
- W1997409302 cites W2051305606 @default.
- W1997409302 cites W2058026390 @default.
- W1997409302 cites W2059225643 @default.
- W1997409302 cites W2061504558 @default.
- W1997409302 cites W2102094003 @default.
- W1997409302 cites W2106839778 @default.
- W1997409302 cites W2112515081 @default.
- W1997409302 cites W2120637696 @default.
- W1997409302 cites W2134177573 @default.
- W1997409302 cites W2156368993 @default.
- W1997409302 cites W2165137027 @default.
- W1997409302 cites W86975699 @default.
- W1997409302 doi "https://doi.org/10.1016/j.nano.2009.10.004" @default.
- W1997409302 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19857606" @default.
- W1997409302 hasPublicationYear "2010" @default.
- W1997409302 type Work @default.
- W1997409302 sameAs 1997409302 @default.
- W1997409302 citedByCount "292" @default.
- W1997409302 countsByYear W19974093022012 @default.
- W1997409302 countsByYear W19974093022013 @default.
- W1997409302 countsByYear W19974093022014 @default.
- W1997409302 countsByYear W19974093022015 @default.
- W1997409302 countsByYear W19974093022016 @default.
- W1997409302 countsByYear W19974093022017 @default.
- W1997409302 countsByYear W19974093022018 @default.
- W1997409302 countsByYear W19974093022019 @default.
- W1997409302 countsByYear W19974093022020 @default.
- W1997409302 countsByYear W19974093022021 @default.
- W1997409302 countsByYear W19974093022022 @default.
- W1997409302 countsByYear W19974093022023 @default.
- W1997409302 crossrefType "journal-article" @default.
- W1997409302 hasAuthorship W1997409302A5036299755 @default.
- W1997409302 hasAuthorship W1997409302A5040938396 @default.
- W1997409302 hasAuthorship W1997409302A5053831779 @default.
- W1997409302 hasAuthorship W1997409302A5069509203 @default.
- W1997409302 hasAuthorship W1997409302A5088889865 @default.
- W1997409302 hasAuthorship W1997409302A5089261501 @default.
- W1997409302 hasConcept C112705442 @default.
- W1997409302 hasConcept C127413603 @default.
- W1997409302 hasConcept C136229726 @default.
- W1997409302 hasConcept C147789679 @default.
- W1997409302 hasConcept C155672457 @default.
- W1997409302 hasConcept C171250308 @default.
- W1997409302 hasConcept C181389837 @default.
- W1997409302 hasConcept C185592680 @default.
- W1997409302 hasConcept C187530423 @default.
- W1997409302 hasConcept C192562407 @default.
- W1997409302 hasConcept C2778049240 @default.
- W1997409302 hasConcept C2778512257 @default.
- W1997409302 hasConcept C2779820397 @default.
- W1997409302 hasConcept C2780165375 @default.
- W1997409302 hasConcept C2780926990 @default.
- W1997409302 hasConcept C42475967 @default.
- W1997409302 hasConcept C43617362 @default.
- W1997409302 hasConcept C501593827 @default.
- W1997409302 hasConcept C55493867 @default.
- W1997409302 hasConcept C71924100 @default.
- W1997409302 hasConcept C80107235 @default.
- W1997409302 hasConcept C86181022 @default.
- W1997409302 hasConcept C98274493 @default.
- W1997409302 hasConceptScore W1997409302C112705442 @default.
- W1997409302 hasConceptScore W1997409302C127413603 @default.
- W1997409302 hasConceptScore W1997409302C136229726 @default.
- W1997409302 hasConceptScore W1997409302C147789679 @default.
- W1997409302 hasConceptScore W1997409302C155672457 @default.